408 related articles for article (PubMed ID: 34549979)
1. Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA.
Smith LM; Ladner JT; Hodara VL; Parodi LM; Harris RA; Callery JE; Lai Z; Zou Y; Raveedran M; Rogers J; Giavedoni LD
J Virol; 2021 Nov; 95(23):e0088221. PubMed ID: 34549979
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
3. Precision Targeted Mutagenesis via Cas9 Paired Nickases in Rice.
Mikami M; Toki S; Endo M
Plant Cell Physiol; 2016 May; 57(5):1058-68. PubMed ID: 26936792
[TBL] [Abstract][Full Text] [Related]
4. Silencing integrated SIV proviral DNA with TAR-specific CRISPR tools.
Smith LM; Hodara VL; Parodi LM; Callery JE; Giavedoni LD
J Med Primatol; 2020 Oct; 49(5):269-279. PubMed ID: 32905624
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats.
Lai M; Maori E; Quaranta P; Matteoli G; Maggi F; Sgarbanti M; Crucitta S; Pacini S; Turriziani O; Antonelli G; Heeney JL; Freer G; Pistello M
J Virol; 2021 Nov; 95(23):e0135821. PubMed ID: 34549986
[TBL] [Abstract][Full Text] [Related]
6. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases.
Cho SW; Kim S; Kim Y; Kweon J; Kim HS; Bae S; Kim JS
Genome Res; 2014 Jan; 24(1):132-41. PubMed ID: 24253446
[TBL] [Abstract][Full Text] [Related]
7. Target-dependent nickase activities of the CRISPR-Cas nucleases Cpf1 and Cas9.
Fu BXH; Smith JD; Fuchs RT; Mabuchi M; Curcuru J; Robb GB; Fire AZ
Nat Microbiol; 2019 May; 4(5):888-897. PubMed ID: 30833733
[TBL] [Abstract][Full Text] [Related]
8. Efficient genome editing by FACS enrichment of paired D10A Cas9 nickases coupled with fluorescent proteins.
Gopalappa R; Song M; Chandrasekaran AP; Das S; Haq S; Koh HC; Ramakrishna S
Arch Pharm Res; 2018 Sep; 41(9):911-920. PubMed ID: 29855892
[TBL] [Abstract][Full Text] [Related]
9. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.
Fu Y; Sander JD; Reyon D; Cascio VM; Joung JK
Nat Biotechnol; 2014 Mar; 32(3):279-284. PubMed ID: 24463574
[TBL] [Abstract][Full Text] [Related]
10. Synthetic gRNA/Cas9 Ribonucleoprotein Inhibits HIV Reactivation and Replication.
Khanal S; Cao D; Zhang J; Zhang Y; Schank M; Dang X; Nguyen LNT; Wu XY; Jiang Y; Ning S; Zhao J; Wang L; Gazzar ME; Moorman JP; Yao ZQ
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146709
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.
Yin C; Zhang T; Qu X; Zhang Y; Putatunda R; Xiao X; Li F; Xiao W; Zhao H; Dai S; Qin X; Mo X; Young WB; Khalili K; Hu W
Mol Ther; 2017 May; 25(5):1168-1186. PubMed ID: 28366764
[TBL] [Abstract][Full Text] [Related]
12. Multiplexed
Ophinni Y; Miki S; Hayashi Y; Kameoka M
Viruses; 2020 Oct; 12(11):. PubMed ID: 33126728
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination.
Herskovitz J; Hasan M; Patel M; Blomberg WR; Cohen JD; Machhi J; Shahjin F; Mosley RL; McMillan J; Kevadiya BD; Gendelman HE
EBioMedicine; 2021 Nov; 73():103678. PubMed ID: 34774454
[TBL] [Abstract][Full Text] [Related]
14. A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures.
Wang G; Zhao N; Berkhout B; Das AT
Cell Rep; 2016 Dec; 17(11):2819-2826. PubMed ID: 27974196
[TBL] [Abstract][Full Text] [Related]
15. Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics.
Dampier W; Sullivan NT; Mell JC; Pirrone V; Ehrlich GD; Chung CH; Allen AG; DeSimone M; Zhong W; Kercher K; Passic S; Williams JW; Szep Z; Khalili K; Jacobson JM; Nonnemacher MR; Wigdahl B
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):950-960. PubMed ID: 29968495
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Cas9 by viral proteins Tat and Rev for HIV-1 inactivation.
Vergara-Mendoza M; Gomez-Quiroz LE; Miranda-Labra RU; Fuentes-Romero LL; Romero-Rodríguez DP; González-Ruiz J; Hernández-Rizo S; Viveros-Rogel M
Antiviral Res; 2020 Aug; 180():104856. PubMed ID: 32579898
[TBL] [Abstract][Full Text] [Related]
17. Genome scale screening identification of SaCas9/gRNAs for targeting HIV-1 provirus and suppression of HIV-1 infection.
Wang Q; Liu S; Liu Z; Ke Z; Li C; Yu X; Chen S; Guo D
Virus Res; 2018 May; 250():21-30. PubMed ID: 29625148
[TBL] [Abstract][Full Text] [Related]
18. Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients.
Sullivan NT; Dampier W; Chung CH; Allen AG; Atkins A; Pirrone V; Homan G; Passic S; Williams J; Zhong W; Kercher K; Desimone M; Li L; C Antell G; Mell JC; Ehrlich GD; Szep Z; Jacobson JM; Nonnemacher MR; Wigdahl B
Sci Rep; 2019 Nov; 9(1):17088. PubMed ID: 31745112
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9 Dual-gRNA Attack Causes Mutation, Excision and Inversion of the HIV-1 Proviral DNA.
Binda CS; Klaver B; Berkhout B; Das AT
Viruses; 2020 Mar; 12(3):. PubMed ID: 32197474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
